Target intelligence / Profile preview

Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1)

Target
CD163L1
Molecular classification
Scavenger receptor, Receptor, Member of the scavenger receptor cysteine-rich (SRCR) superfamily
01

Overview

Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1) is a membrane protein from the scavenger receptor cysteine-rich (SRCR) superfamily, structurally characterized by twelve SRCR domains, a transmembrane region, and a cytoplasmic domain[1][3][7]. It is primarily expressed on subsets of tissue macrophages and is involved in endocytic uptake, likely through a clathrin-mediated pathway[2]. While sharing homology with the hemoglobin scavenger receptor CD163, CD163L1 shows a distinct expression pattern and does not bind classical CD163 ligands such as haptoglobin–hemoglobin complexes[2]. CD163L1 expression in macrophages is regulated by cytokines, being upregulated by IL-6 and IL-10 and downregulated by proinflammatory signals such as IL-4, IL-13, TNF-α, and LPS/IFN-γ[2]. Although its functions are not as well defined as CD163, it is postulated to act as a scavenger receptor important for resolution of inflammation, making it relevant for immunological and inflammatory research[2][3]. The protein is encoded by the CD163L1 gene (NCBI Gene ID: 283316)[1][3]. There is no evidence of direct drug targeting, biomarker status, or noted safety concerns at present.

Other names
CD163BM160SCARI2WC1CD163 antigen-like 1CD163 antigen BSTARCD163 molecule like 1
02

Biological functions

Immune responseEndocytosisLigand uptake/binding
03

Disease associations

InflammationDiverticulitisOther (potential/modulating role in inflammatory diseases)

Beyond the preview

Go deeper on Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call